Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q/A
Source: 0001731122-25-000254
Chunk: 31

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q/A
Chunk 31
---
|:--|:------------|:--|
| Revenues                                          |     | $ | —           |   |
| Net loss                                          |     | $ | (48,406,163 | ) |

Consolidated unaudited pro forma information:

The following consolidated pro
forma information assumes that the acquisition of Renovaro Cube took place on July 1, 2023 for the statement of operations for the three-month
period ended September 30, 2023. These amounts have been estimated after applying the Company’s accounting policies:

| Schedule of consolidated proforma information |     |   |             |   |
|:----------------------------------------------|:----|:--|:------------|:--|
| Revenues                                      |     | $ | —           |   |
| Net loss                                      |     | $ | (13,146,452 | ) |

The
unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results
of operations would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future
results of operations.

NOTE 12 — SUBSEQUENT EVENTS

From October 21, 2024, to November
6, 2024, the Company issued Promissory Notes in the aggregate principal amount of $900,000. The Notes bear an interest rate ranging from
10% to 12% per annum and mature from December 31, 2024, to January 31, 2025 (the “Maturity Date”). The Company is required
to pay principal and interest on the Maturity Date.

On October 17, 2024, the Company
entered into an investor relations consulting agreement with MZHCI, LLC. Pursuant to the agreement, the Company issued 160,000 shares
of Common Stock to MZHCI, LLC valued at $118,400.

On October 14, 2024, the
Company issued 250,000 shares of Common Stock as part of a sign on bonus valued at $137,500 to the Chief Executive Officer effective
October 14, 2024, David Weinstein.

On October 14, 2024, the
Company issued 500,000 shares of Common Stock for consulting services valued at $275,000.

Related to the June 2024 Private
Placement, ranging from October 2, 2024, to October 10, 2024, the Company sold 190,140 Units